Gilbert D Ezell, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 5651 Frist Blvd, Ste 616, Hermitage, TN 37076 Phone: 615-391-4394 Fax: 615-391-0284 |
Michael James Belsante, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 5651 Frist Blvd, #616, Hermitage, TN 37076 Phone: 615-391-4394 Fax: 615-391-4491 |
Dr. Christopher Heath Meyers Hawkins, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5651 Frist Blvd., Ste 616, Hermitage, TN 37076 Phone: 615-391-4394 Fax: 615-391-0284 |
News Archive
A double-blind, randomized, placebo-controlled clinical trial has recently demonstrated that Ivermectin, an anti-parasitic drug, can reduce in-hospital mortality rate of COVID-19 patients.
Kadimastem, an Israeli Biotechnology company that develops human pluripotent stem cell-related products, today announced the signing of a five year framework agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany.
Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages 6-11 with uncontrolled moderate-to-severe asthma, compared to placebo, according to research presented at the ATS 2021 International Conference. VOYAGE (NCT02948959) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial, that took place in a number of countries.
Atherosclerosis-;the narrowing of arteries due to plaque buildup-;is the underlying reason for the majority of strokes and heart attacks. When atherosclerosis occurs in the arteries that carry blood to the heart muscle, it is called coronary artery disease, the No. 1 killer of Americans.
› Verified 4 days ago